CDT Equity Inc. SEC filings CDTTW
CDT Equity Inc. has 368 filings in SEC EDGAR's recent list, going back to Dec 9, 2021. Its latest annual report, Form ARS, was filed on Aug 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (change to shareholder rights, bylaw or fiscal year change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Nov 4, 2026 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Nov 4, 2026 | Nov 2, 2026 |
| 424B3 | Prospectus | Nov 3, 2026 | — |
| DEF 14A | Proxy statement | Oct 27, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 27, 2026 | Oct 22, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 16, 2026 | Oct 16, 2026 |
| 424B3 | Prospectus | Oct 13, 2026 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 13, 2026 | Oct 6, 2026 |
| 424B3 | Prospectus | Oct 2, 2026 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Sep 25, 2026 | Sep 24, 2026 |
| 424B3 | Prospectus | Sep 18, 2026 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Sep 18, 2026 | Sep 14, 2026 |
| 424B3 | Prospectus | Sep 18, 2026 | — |
| EFFECT | Filing | Sep 17, 2026 | — |
| S-1 | Registration statement | Sep 8, 2026 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Sep 4, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Other events
|
Sep 1, 2026 | Aug 28, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Sep 1, 2026 | Aug 28, 2026 |
| 8-K/A | Amended current report | Aug 21, 2026 | Jul 30, 2026 |
| 8-K/A |
Amended current report
Acquisition or sale of assets
|
Aug 21, 2026 | Feb 19, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| DEFA14A | Additional proxy material | Aug 12, 2026 | — |
| ARS | Annual report to shareholders | Aug 11, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 6, 2026 | Jul 31, 2026 |
| 8-K/A |
Amended current report
Acquisition or sale of assets
|
Aug 3, 2026 | Jul 30, 2026 |
| PRE 14A | Preliminary proxy statement | Jul 31, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 31, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Jul 29, 2026 | Jul 24, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Jul 16, 2026 | Jul 15, 2026 |
| 10-Q | Quarterly report | Jul 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Auditor change
|
Jun 29, 2026 | Jun 23, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Jun 16, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
May 28, 2026 | May 21, 2026 |
| NT 10-Q | Filing | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement
|
May 15, 2026 | May 15, 2026 |
| EFFECT | Filing | May 1, 2026 | — |
| 424B3 | Prospectus | May 1, 2026 | — |
| CORRESP | Letter to the SEC | Apr 30, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 29, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Apr 27, 2026 | Apr 27, 2026 |
| S-3 | Shelf registration | Apr 22, 2026 | — |
| 10-K | Annual report | Apr 15, 2026 | Dec 31, 2025 |
| 424B5 | Prospectus supplement | Apr 2, 2026 | — |
| NT 10-K | Filing | Apr 1, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 25, 2026 | Mar 24, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Mar 18, 2026 | Mar 17, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Mar 9, 2026 | Mar 3, 2026 |
| DEF 14A | Proxy statement | Mar 6, 2026 | Mar 6, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 24, 2026 | Feb 19, 2026 |
| PRE 14A | Preliminary proxy statement | Feb 24, 2026 | Feb 24, 2026 |
| 424B3 | Prospectus | Feb 10, 2026 | — |
| EFFECT | Filing | Feb 9, 2026 | — |
| CORRESP | Letter to the SEC | Feb 6, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 6, 2026 | — |
| S-8 | Employee stock plan registration | Jan 30, 2026 | — |
| S-3 | Shelf registration | Jan 30, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 22, 2026 | Jan 16, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jan 2, 2026 | Dec 28, 2025 |
| S-8 POS | Filing | Dec 12, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 12, 2025 | Dec 8, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Oct 9, 2025 | Oct 8, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 10-Q/A | Amended quarterly report | Aug 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Restatement
|
Aug 14, 2025 | Aug 8, 2025 |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| S-8 | Employee stock plan registration | Aug 11, 2025 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Aug 8, 2025 | Aug 4, 2025 |
| EFFECT | Filing | Aug 7, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 5, 2025 | — |
| CORRESP | Letter to the SEC | Aug 5, 2025 | — |
| S-3 | Shelf registration | Jul 31, 2025 | — |
| DEF 14A | Proxy statement | Jul 8, 2025 | Jul 8, 2025 |
| ARS | Annual report to shareholders | Jul 8, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jun 9, 2025 | Jun 3, 2025 |
| 8-K | Current report | Jun 3, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
May 16, 2025 | May 15, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 6, 2025 | May 5, 2025 |
| EFFECT | Filing | Apr 30, 2025 | — |
| CORRESP | Letter to the SEC | Apr 28, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Apr 25, 2025 |
| 8-K |
Current report
Auditor change
|
Apr 25, 2025 | Apr 24, 2025 |
| S-3 | Shelf registration | Apr 22, 2025 | — |
| PRE 14A | Preliminary proxy statement | Apr 16, 2025 | Apr 16, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 16, 2025 | Apr 12, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 4, 2025 | Mar 31, 2025 |
| 8-K/A |
Amended current report
Other events
|
Apr 2, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Other events
|
Apr 1, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 28, 2025 | Dec 31, 2024 |
| 424B5 | Prospectus supplement | Mar 10, 2025 | — |
| 8-K |
Current report
Other events
|
Mar 6, 2025 | Mar 5, 2025 |
| 8-K |
Current report
Agreement ended, Listing notice, Other events
|
Feb 19, 2025 | Feb 12, 2025 |
| 424B5 | Prospectus supplement | Feb 19, 2025 | — |
| 424B3 | Prospectus | Feb 14, 2025 | — |
| EFFECT | Filing | Feb 12, 2025 | — |
| CORRESP | Letter to the SEC | Feb 11, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2025 | — |
| 8-K |
Current report
Other events
|
Feb 11, 2025 | Feb 7, 2025 |
| 424B5 | Prospectus supplement | Feb 10, 2025 | — |
| S-8 | Employee stock plan registration | Feb 6, 2025 | — |
| 424B5 | Prospectus supplement | Feb 6, 2025 | — |
| S-3 | Shelf registration | Feb 5, 2025 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Jan 23, 2025 | Jan 22, 2025 |
| 424B5 | Prospectus supplement | Jan 15, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Jan 14, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Listing notice, Shareholder vote results
|
Dec 20, 2024 | Dec 17, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 17, 2024 | Dec 12, 2024 |
| 424B3 | Prospectus | Dec 16, 2024 | — |
| 424B3 | Prospectus | Dec 9, 2024 | — |
| DEF 14A | Proxy statement | Dec 6, 2024 | Dec 6, 2024 |
| EFFECT | Filing | Dec 6, 2024 | — |
| CORRESP | Letter to the SEC | Dec 4, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 2, 2024 | — |
| PRE 14A | Preliminary proxy statement | Nov 26, 2024 | Nov 26, 2024 |
| S-3 | Shelf registration | Nov 25, 2024 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Nov 25, 2024 | Nov 22, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Nov 19, 2024 | Nov 14, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 10-Q/A | Amended quarterly report | Nov 14, 2024 | Jun 30, 2024 |
| 10-Q/A | Amended quarterly report | Nov 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Restatement
|
Nov 14, 2024 | Nov 12, 2024 |
| 424B5 | Prospectus supplement | Nov 4, 2024 | — |
| 424B3 | Prospectus | Nov 4, 2024 | — |
| EFFECT | Filing | Nov 1, 2024 | — |
| DEFA14A | Additional proxy material | Nov 1, 2024 | — |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
|
Nov 1, 2024 | Oct 28, 2024 |
| CORRESP | Letter to the SEC | Oct 31, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 29, 2024 | — |
| ARS | Annual report to shareholders | Oct 28, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Oct 28, 2024 | — |
| DEF 14A | Proxy statement | Oct 28, 2024 | Oct 28, 2024 |
| S-3 | Shelf registration | Oct 24, 2024 | — |
| PRE 14A | Preliminary proxy statement | Oct 16, 2024 | Oct 16, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Oct 15, 2024 | Oct 9, 2024 |
| 424B3 | Prospectus | Sep 17, 2024 | — |
| EFFECT | Filing | Sep 16, 2024 | — |
| CORRESP | Letter to the SEC | Sep 16, 2024 | — |
| S-1/A | Amended registration statement | Sep 13, 2024 | — |
| 8-K | Current report | Sep 6, 2024 | Sep 6, 2024 |
| S-1 | Registration statement | Sep 4, 2024 | — |
| 424B3 | Prospectus | Aug 19, 2024 | — |
| 8-K |
Current report
Listing notice, Other events
|
Aug 16, 2024 | Aug 15, 2024 |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 8, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 7, 2024 | Aug 6, 2024 |
| 8-K/A | Amended current report | Jul 11, 2024 | Jul 1, 2024 |
| 8-K | Current report | Jul 1, 2024 | Jul 1, 2024 |
| 8-K |
Current report
Listing notice
|
May 31, 2024 | May 28, 2024 |
| 424B3 | Prospectus | May 16, 2024 | — |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| EFFECT | Filing | May 2, 2024 | — |
| POS AM | Filing | May 2, 2024 | — |
| 10-K | Annual report | Apr 16, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Restatement
|
Apr 16, 2024 | Apr 11, 2024 |
| NT 10-K | Filing | Apr 1, 2024 | Dec 31, 2023 |
| S-8 | Employee stock plan registration | Jan 10, 2024 | — |
| 424B3 | Prospectus | Dec 18, 2023 | — |
| EFFECT | Filing | Dec 15, 2023 | — |
| CORRESP | Letter to the SEC | Dec 13, 2023 | — |
| S-8 | Employee stock plan registration | Dec 1, 2023 | — |
| CORRESP | Letter to the SEC | Dec 1, 2023 | — |
| S-1/A | Amended registration statement | Dec 1, 2023 | — |
| 10-Q/A | Amended quarterly report | Nov 21, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Nov 20, 2023 | Sep 30, 2023 |
| NT 10-Q | Filing | Nov 14, 2023 | Sep 30, 2023 |
| UPLOAD | Letter from the SEC | Oct 30, 2023 | — |
| S-1 | Registration statement | Oct 17, 2023 | — |
| 8-K/A |
Amended current report
Material agreement, Acquisition or sale of assets, Listing notice, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Oct 5, 2023 | Sep 22, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Listing notice, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Sep 29, 2023 | Sep 22, 2023 |
| 25-NSE | Delisting notice | Sep 22, 2023 | — |
| CERT | Filing | Sep 22, 2023 | — |
| 8-A12B | Filing | Sep 22, 2023 | — |
| 8-K |
Current report
Shareholder vote results, Other events
|
Sep 21, 2023 | Sep 20, 2023 |
| 424B3 | Prospectus | Sep 13, 2023 | — |
| 425 | Filing | Sep 13, 2023 | — |
| 8-K |
Current report
Material agreement, Other events
|
Sep 13, 2023 | Sep 13, 2023 |
| 425 | Filing | Sep 7, 2023 | — |
| 8-K |
Current report
Other events
|
Sep 7, 2023 | Sep 7, 2023 |
| 425 | Filing | Aug 31, 2023 | — |
| 8-K |
Current report
Other events
|
Aug 31, 2023 | Aug 31, 2023 |
| 425 | Filing | Aug 23, 2023 | — |
| 8-K |
Current report
Other events
|
Aug 23, 2023 | Aug 23, 2023 |
| 424B3 | Prospectus | Aug 23, 2023 | — |
| 425 | Filing | Aug 16, 2023 | — |
| 8-K |
Current report
Other events
|
Aug 16, 2023 | Aug 16, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| SEC STAFF LETTER | Filing | Aug 11, 2023 | — |
| EFFECT | Filing | Aug 11, 2023 | — |
| 424B3 | Prospectus | Aug 11, 2023 | — |
| CORRESP | Letter to the SEC | Aug 10, 2023 | — |
| CORRESP | Letter to the SEC | Aug 8, 2023 | — |
| S-4/A | Filing | Aug 8, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2023 | — |
| S-4/A | Filing | Jul 28, 2023 | — |
| CORRESP | Letter to the SEC | Jul 28, 2023 | — |
| 425 | Filing | Jul 21, 2023 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CDT (Nasdaq), CDTTW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Naples, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1896212
- Former names
- CONDUIT PHARMACEUTICALS INC. (until Aug 7, 2025); Murphy Canyon Acquisition Corp. (until Sep 21, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.